Picture Berlin Partner HealthCapital Bionnale 2019 Germany May 650x80px

Document › Details

CRISPR Therapeutics AG. (2/12/20). "Press Release: CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2019 Financial Results". Zug & Cambridge, MA.

	Organisation	CRISPR Therapeutics AG (Nasdaq: CRSP)
	Group	CRISPR Therapeutics (Group)
	Organisation 2	Vertex Pharmaceuticals Inc. (Nasdaq: VRTX)
	Group	Vertex Pharmaceuticals (Group)
	Product	CTX001 (CRISPR Therapeutics/Vertex)
	Product 2	CTX110 allogeneic CAR-T cell therapy
	Person	Kulkarni, Samarth (Sam) (CRISPR Therapeutics 201712– promoted CEO before CBO)
	Person 2	Kim, Susan (CRISPR Therapeutics 201809 Investor Relations)

Original document
accessed by [iito] on 2020-02-26

Record changed: 2020-03-02

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 650x65px

More documents for CRISPR Therapeutics (Group)

[1] CRISPR Therapeutics AG. (2/26/20). "Press Release: CRISPR Therapeutics Proposes Changes to the Board of Directors". Zug & Cambridge, MA....
[2] CRISPR Therapeutics AG. (11/20/19). "Press Release: CRISPR Therapeutics Announces Pricing of Public Offering of Common Shares". Zug & Cambridge, MA....
[3] CRISPR Therapeutics AG. (11/19/19). "Press Release: CRISPR Therapeutics Announces Proposed Public Offering of Common Shares". Zug & Cambridge, MA....
[4] CRISPR Therapeutics AG. (11/19/19). "Press Release: CRISPR Therapeutics and Vertex Announce Positive Safety and Efficacy Data From First Two Patients Treated With Investigational CRISPR/Cas9 Gene-Editing Therapy CTX001 for Severe Hemoglobinopathies". Zug...
[5] CRISPR Therapeutics AG. (10/28/19). "Press Release: CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2019 Financial Results". Zug & Cambridge, MA....
[6] CRISPR Therapeutics AG. (10/21/19). "Press Release: CRISPR Therapeutics and Bayer Announce an Update on Casebia Therapeutics". Leverkusen, Zug & Cambridge, MA....
[7] CRISPR Therapeutics AG. (10/15/19). "Press Release: CRISPR Therapeutics and KSQ Therapeutics Announce License Agreement to Advance Companies’ Respective Cell Therapy Programs in Oncology". Zug & Cambridge, MA....
[8] CRISPR Therapeutics AG. (9/17/19). "Press Release: CRISPR Therapeutics and ViaCyte Present Positive In Vitro Data Towards a Potential Immune-Evasive Cell Replacement Therapy for Diabetes at EASD 2019". Zug, Cambridge, MA & San Diego, CA....
[9] Vertex Pharmaceuticals Inc.. (6/6/19). "Press Release: Vertex Expands into New Disease Areas and Enhances Gene Editing Capabilities Through Expanded Collaboration with CRISPR Therapeutics and Acquisition of Exonics Therapeutics". Boston, MA & Watertown,...
[10] CRISPR Therapeutics AG. (4/29/19). "Press Release: CRISPR Therapeutics Provides Business Update and Reports First Quarter 2019 Financial Results". Zug & Cambridge, MA....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]